CVS Stock Price - CVS Health Corp. Stock Quote (U.S.: NYSE) - MarketWatch

Open $66.99
Day Range 65.51 - 67.50
52 Week Range 60.14 - 84.00
Market Cap $69.19B
Shares Outstanding 1.02B
Public Float 1.01B
Beta 0.83
Rev. per Employee $751.08K
P/E Ratio 10.16
EPS $6.47
Yield 3.04%
Dividend $0.50
Ex-Dividend Date Apr 20, 2018
Short Interest 43.35M 04/13/18
% of Float Shorted 4.28%
Average Volume 8.9M

5 Day	-3.00%
1 Month	2.20%
3 Month	-16.51%
YTD	-9.39%
1 Year	-17.57%

MarketWatch
Other Dow Jones

CVS Health shares down 3.6% in Wednesday trading

May. 2, 2018 at 11:51 a.m. ET
by Tonya Garcia

CVS Health upgraded to buy from hold at CFRA, maintains $79 price target

May. 2, 2018 at 11:51 a.m. ET
by Tonya Garcia

S&P 500, Dow slip ahead of Fed, but Nasdaq buoyed by Apple’s stock rally

May. 2, 2018 at 11:36 a.m. ET
by Victor Reklaitis

Once-hated energy stocks are now too popular — here’s when to plunge in

May. 2, 2018 at 9:10 a.m. ET
by Victor Reklaitis

CVS shares rise after profit beats views

CVS Health Corp.'s revenue rose as it filled more prescriptions and benefited from a lower effective tax rate. The drugstore chain said Wednesday its first-quarter revenue increased 2.6% from a year ago to $45.7 billion, up from $44.5 billion a year ago. Revenue jumped 5.6% in its retail and long-term care segment as same-store prescription volumes rose 8.5%.

May. 2, 2018 at 7:45 a.m. ET
by MarketWatch.com

CVS shares rise after profit beat, upbeat 2018 guidance

CVS Health Corp. shares rose 1.5% in premarket trade Wednesday after the company reported a first-quarter profit beat and upbeat 2018 guidance. Earnings for the latest quarter rose to $998 million, or 98 cents per share, from $953 million, or 92 cents per share in the year-earlier period. Adjusted earnings-per-share were $1.48, compared with the FactSet consensus of $1.41. The latest earnings results include a $153 million increase in operating profit and a $221 million interest expense increase related to the company's planned Aetna acquisition. Revenue rose to $45.69 billion from $44.51 billion, compared with the FactSet consensus of $45.8 billion. CVS expects 2018 EPS of $5.11 to $5.32 and 2018 adjusted EPS of $6.87 to $7.08, above the FactSet consensus of $6.47. In the second quarter, CVS expects EPS of $1.21 to $1.26 and adjusted EPS of $1.59 to $1.64. CVS also said it received a second request for information from the Department of Justice in February regarding the Aetna acquisition; it still expects the transaction to close by the second half of the year. CVS shares have dropped 11% over the last three months, compared with a nearly 4% drop in the S&P 500 and a 5.6% drop in the Dow Jones Industrial Average .

May. 2, 2018 at 7:09 a.m. ET
by Emma Court

CVS's stock surges 1.5% premarket after Q1 results

May. 2, 2018 at 7:01 a.m. ET
by Tomi Kilgore

CVS Q1 pharmacy same-store sales up 7.3%; FactSet consensus up 5.2%

May. 2, 2018 at 7:01 a.m. ET
by Tomi Kilgore

CVS Q1 same-store sales rose 4.8%; FactSet consensus 4.6%

May. 2, 2018 at 7:00 a.m. ET
by Tomi Kilgore

CVS sees Aetna deal closing in the 2nd-half of the year

May. 2, 2018 at 7:00 a.m. ET
by Tomi Kilgore

CVS Q1 revenue $45.69 bln vs. $44.51 bln; FactSet consensus $45.77 bln

May. 2, 2018 at 6:58 a.m. ET
by Tomi Kilgore

CVS Q1 adj. EPS $1.48; FactSet consensus $1.41

May. 2, 2018 at 6:58 a.m. ET
by Tomi Kilgore

CVS Q1 EPS 98 cents vs. 92 cents a year ago

May. 2, 2018 at 6:57 a.m. ET
by Tomi Kilgore

Search this year’s most battered stock-market sector for quality contrarian plays

Apr. 30, 2018 at 12:03 p.m. ET
by Philip van Doorn

Wegmans EpiPens out of stock, but no U.S. shortage currently seen, FDA says

In spite of reports that Wegmans pharmacies are out of stock of the EpiPen allergic reaction treatment, the Food and Drug Administration is not currently aware of any U.S. shortage, though the regulator continues to monitor the supply, spokesperson Lauren Smith Dyer. Pfizer , which manufactures the Mylan product through one of its business units, said that it is currently shipping products but supplies may vary from pharmacy to pharmacy. EpiPen shortages have been seen in Canada and the United Kingdom, and Canada recently said it is working with the U.S. to alleviate the shortage. "We understand how important this potentially life-saving product is to patients, and we are working closely with Mylan to monitor supply levels so patients have access to epinephrine auto injector products," Pfizer spokesperson Steve Danehy said. MarketWatch's requests for comment to to Mylan and many U.S. pharmacy chains were not immediately returned.

Apr. 24, 2018 at 11:07 a.m. ET
by Emma Court

Aetna to reorganize ahead of CVS deal

Aetna Inc. said Tuesday afternoon it would reorganize its business units ahead of its expected acquisition by CVS Health Corp. Aetna said it would break its business down into a health-care segment and a "Corporate/Other" category, which will include discontinued products, divested contracts and corporate expenses that do not support Aetna's business operations. The company restated previous financial statements to reflect the change in Tuesday's announcement, and will present financials in the new fashion when reporting first-quarter earnings May 1. CVS announced plans to buy Aetna for about $69 billion in cash and stock last December.

Apr. 17, 2018 at 6:14 p.m. ET
by Jeremy C. Owens

Drug players’ shares spike on report that Amazon no longer plans to sell pharmaceuticals

Apr. 17, 2018 at 6:55 a.m. ET
by Emma Court

CVS launches program aimed at tackling high cost of medication

Drug store chain CVS Health Corp. said Wednesday it is launching a program aimed at helping its customers, pharmacists and doctors tackle the rising costs of medication. The company said its new CVS Pharmacy Rx Savings Finder will enable retail pharmacists to quickly find prescription savings, including medications for many common or chronic conditions that are available for zero copay. It will also provide prescribers with access to lower-cost medications through their electronic health record system and to CVS Caremark members through the member portal and updated app. "Today's consumers are faced with higher prescription drug prices than ever before and many of them are now paying for a larger share of their prescription drug costs out of their own pockets at the pharmacy counter due to growth in high deductible health plans," said Thomas Moriarty, Chief Policy and External Affairs Officer, CVS Health. CVS shares were slightly lower premarket and have lost 18% in the last 12 months, while the S&P 500 has gained 13%.

Apr. 11, 2018 at 7:15 a.m. ET
by Ciara Linnane

CVS is making a medical device, showing how health-care companies are doing more

Apr. 8, 2018 at 11:57 a.m. ET
by Emma Court

Weekend roundup: Odds of a real trade war | Don’t ignore this other threat to investors from China | How accurate is Trump’s data?

Apr. 7, 2018 at 7:43 a.m. ET
by Philip van Doorn

Slurpees vs. Kale: 7-Eleven Struggles to Catch Fresh-Food Wave

The convenience-store chain is falling behind rivals that are gleaning more sales from healthier snacks and freshly cooked meals.

May. 2, 2018 at 9:59 a.m. ET
on The Wall Street Journal

Stocks to Watch: Apple, T-Mobile, Mastercard, Snap, CVS, Mondelez, Xerox, Gilead, Clorox, Allstate, Coors

Among the companies with shares expected to trade actively in Wednesday's session are Apple, T-Mobile, Mastercard, Snap, CVS Health and Mondelez.

May. 2, 2018 at 9:29 a.m. ET
on The Wall Street Journal

CVS Gets a Lift From Prescriptions

CVS Health’s revenue rose as it filled more prescriptions and its earnings benefited from a lower effective tax rate.

May. 2, 2018 at 7:36 a.m. ET
on The Wall Street Journal

Retail’s Other Problem: Too Few Clerks in the Store

Many of America’s biggest retailers, under assault from Amazon, have been slashing staff even faster than they have been closing stores, a dynamic that has left fewer clerks and longer checkout lines.

Apr. 30, 2018 at 5:30 a.m. ET
on The Wall Street Journal

In This Earnings Season, The Beats Roll On

Analysts can’t get much sleep as first-quarter earnings continue to pour in. And they’re running out of superlatives. But investors aren’t as impressed.

Apr. 28, 2018 at 12:01 a.m. ET
on Barron's Online

Clouds From the Retail Storm Reach Hawaii Real Estate

Hawaii is a market where national retailers typically rack up higher-than-average store sales and enjoy low vacancy rates. But headwinds from the continental U.S. are starting to reach America’s 50th state.

Apr. 24, 2018 at 3:50 p.m. ET
on The Wall Street Journal

U.S. Stocks Jump on Strong Corporate Results

Transportation companies boosted major indexes Monday, as some strong corporate-profit reports helped investors look past simmering geopolitical tensions.

Apr. 16, 2018 at 5:18 p.m. ET
on The Wall Street Journal

Rate Rises Begin to Bite, With More Pain to Come

After years of rock-bottom rates and low interest expenses, companies will find refinancing a painful process.

Apr. 13, 2018 at 12:59 p.m. ET
on Barron's Online

Rite Aid Shareholders Sour on Albertsons Deal

Some Rite Aid shareholders plan to oppose a merger with grocer Albertsons Cos. that they believe undervalues the struggling pharmacy chain.

Apr. 12, 2018 at 4:51 p.m. ET
on The Wall Street Journal

Stocks to Watch: Facebook, Sprint, CVS, JetBlue, eBay, Analogic, Carnival, P&G, Devon, Fastenal

Among the companies with shares expected to trade actively in Wednesday's session are Facebook, Sprint, CVS Health, JetBlue Airways, eBay and Analogic.

Apr. 11, 2018 at 9:17 a.m. ET
on The Wall Street Journal

Anthem May Win by Sitting Out Wave of Health Insurance Deals

Anthem may be smart in sitting out the recent deal-making in insurance. Some proposed deals haven’t been popular with shareholders, and approvals may be difficult. Anthem can always make a move later.

Apr. 6, 2018 at 5:30 a.m. ET
on The Wall Street Journal

Surgeon General Urges Public to Carry Overdose Reversal Medication

The U.S. Surgeon General on Thursday urged individuals and families at risk of opioid abuse to keep naloxone on hand, which rapidly reverses an overdose of drugs such as morphine and heroin.

Apr. 5, 2018 at 12:05 p.m. ET
on The Wall Street Journal

The Stores That Track Your Returns

Best Buy has drawn criticism for using Retail Equation to generate consumers’ ‘risk score.’ Other retailers using the firm include J.C. Penney, Sephora, CVS and Victoria’s Secret.

Apr. 4, 2018 at 8:00 a.m. ET
on The Wall Street Journal

Buyout Target Express Scripts Has 30%-Plus Upside

Cigna’s purchase will likely close by year-end. The deal spread has widened to about 30% and Express Scripts trades below where it did prior to the deal announcement.

Apr. 3, 2018 at 3:06 p.m. ET
on Barron's Online

Hospitals Fear Threat From Potential Walmart-Humana Deal

Early-stage deal talks between Walmart and Humana are deepening anxiety in the hospital sector, which is already grappling with sluggish growth and competition from cheaper health-care options.

Apr. 1, 2018 at 9:00 a.m. ET
on The Wall Street Journal

The Danger Lurking in a Safe Corner of the Bond Market

U.S. companies have been bulking up on debt, introducing another wild card into markets already rattled by the recent tech selloff and the prospect of rising interest rates.

Apr. 1, 2018 at 8:00 a.m. ET
on The Wall Street Journal

The FANG Stocks Bite Back

After going on a long upward flight, some of them are crashing back to earth. Also, the yield curve sends a danger signal.

Mar. 31, 2018 at 12:01 a.m. ET
on Barron's Online

Walmart Courts New Risk in Its Hunt for Humana

Walmart’s potential acquisition of a health insurer would push it far beyond its big-box roots, enabling it to diversify away from the competitive pressures of retailing yet also thrusting it into a complicated and rapidly evolving health-care sector.

Mar. 30, 2018 at 9:13 p.m. ET
on The Wall Street Journal

Healthy Skepticism About Walmart and Humana

There is a method to the madness of retailers that want to buy health insurers, but Wall Street still isn’t crazy about it.

Mar. 30, 2018 at 11:53 a.m. ET
on The Wall Street Journal

Walmart: Here’s What It Might Have to Pay for Humana

Perhaps as much as $50 billion, according to one estimate.

Mar. 30, 2018 at 10:09 a.m. ET
on Barron's Online

Other News
Press Releases

CVS Health Punished for Top-Line Miss

The Rhode Island–based CVS Health (CVS) reported results for 1Q18 before the morning bell today.

May. 2, 2018 at 11:45 a.m. ET
on MarketRealist.com

CVS Health Corporation 2018 Q1 - Results - Earnings Call Slides

May. 2, 2018 at 10:35 a.m. ET
on Seeking Alpha

Slurpees vs. Kale: 7-Eleven Struggles to Catch Fresh-Food Wave

The convenience-store chain is falling behind rivals that are gleaning more sales from healthier snacks and freshly cooked meals.

May. 2, 2018 at 9:59 a.m. ET
on The Wall Street Journal

CVS Health Q1 revenues up 3%; non-GAAP EPS 27%; updates guidance; shares ahead 5% premarket

May. 2, 2018 at 7:29 a.m. ET
on Seeking Alpha

CVS Gets a Lift From Prescriptions

CVS Health’s revenue rose as it filled more prescriptions and its earnings benefited from a lower effective tax rate.

May. 2, 2018 at 7:36 a.m. ET
on The Wall Street Journal

CVS Health Q1 revenues uo 3%; non-GAAP EPS 27%; updates guidance; shares ahead 5% premarket

May. 2, 2018 at 7:29 a.m. ET
on Seeking Alpha

Notable earnings before Wednesday’s open

May. 1, 2018 at 5:30 p.m. ET
on Seeking Alpha

3 Reasons to Consider Buying CVS Health Stock Before Earnings

May. 1, 2018 at 12:32 p.m. ET
on InvestorPlace.com

Aetna Inc (AET) Slims and Trims Before Marriage to CVS

May. 1, 2018 at 11:48 a.m. ET
on InvestorPlace.com

CVS Health Reports Earnings in Recovery Mode

Drug store chain CVS Health Corporation is too cheap to ignore, with a P/E ratio of just 10.81 and a dividend yield of 2.86%.

May. 1, 2018 at 10:17 a.m. ET
on Investopedia.com

4 Things to Expect in CVS Health's Q1 Earnings Results

May. 1, 2018 at 6:32 a.m. ET
on Motley Fool

Vulcan Value Partners Commentary - Q1 2018

May. 1, 2018 at 5:15 a.m. ET
on Seeking Alpha

CVS: Going Long, And Understanding The Aetna Deal

Apr. 30, 2018 at 11:55 a.m. ET
on Seeking Alpha

How Did CVS Health’s 1Q18 Shape Up?

CVS Health is expecting a 0.5% to 4.5% increase in adjusted operating profit during the first quarter of 2018.

Apr. 30, 2018 at 8:40 a.m. ET
on MarketRealist.com

CVS Set to Post 1Q18 Results on May 2: What to Expect

CVS Health (CVS) is expected to report a 19.7% YoY (year-over-year) increase in earnings to $1.40 per share in 1Q18.

Apr. 30, 2018 at 8:40 a.m. ET
on MarketRealist.com

Retail’s Other Problem: Too Few Clerks in the Store

Apr. 30, 2018 at 5:30 a.m. ET
on The Wall Street Journal

Alibaba, CVS, Tesla and Other Earnings to Watch For This Week

24/7 Wall St. has put together a preview of Alibaba, CVS, Tesla and some of the other most anticipated earnings reports due in the coming week.

Apr. 29, 2018 at 9:31 a.m. ET
on 247WallSt.com

DivGro Pulse: April 2018

Apr. 27, 2018 at 3:48 p.m. ET
on Seeking Alpha

CVS Health: A Store-Level Look At The Proposed Healthcare Giant

Apr. 26, 2018 at 4:15 p.m. ET
on Seeking Alpha

Aetna Inc Stock Is Low-Risk, Big-Reward at Current Levels

Apr. 25, 2018 at 11:01 a.m. ET
on InvestorPlace.com

CVS Health Recognized By DiversityInc as Top 50 Company for Diversity For Second Year in a Row

May. 2, 2018 at 10:00 a.m. ET
on PR Newswire - PRF

CVS Health Reports First Quarter Results And Confirms 2018 Full Year Outlook

May. 2, 2018 at 6:55 a.m. ET
on PR Newswire - PRF

CVS Health Underscores Commitment to Safe Medication Disposal Ahead of National Prescription Drug Take-Back Day on April 28

Apr. 26, 2018 at 8:45 a.m. ET
on PR Newswire - PRF

CVS Health Releases 11th Annual Corporate Social Responsibility Report

Apr. 25, 2018 at 8:00 a.m. ET
on PR Newswire - PRF

CVS Health Corporation To Hold First Quarter 2018 Conference Call

Apr. 20, 2018 at 12:00 p.m. ET
on PR Newswire - PRF

CVS Pharmacy Offering Hepatitis A Vaccine to Kentuckians Following an Increase in Confirmed Cases of the Virus

Apr. 20, 2018 at 9:24 a.m. ET
on PR Newswire - PRF

CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Ohio to Help Combat Opioid Abuse

Apr. 19, 2018 at 8:45 a.m. ET
on PR Newswire - PRF

CVS Pharmacy Launches First Campaign Featuring Unaltered Beauty Imagery

Apr. 19, 2018 at 8:30 a.m. ET
on PR Newswire - PRF

EX-Dividend Schedule: CVS Health Has a Dividend Yield of 3.03%; Will Trade Ex-Dividend on April 20, 2018

Apr. 19, 2018 at 7:50 a.m. ET
on ACCESSWIRE

Phoenix VA Health Care System, TriWest and CVS Health Mark First Anniversary of Program that Expands Veterans' Access to Health Care

Apr. 18, 2018 at 8:30 a.m. ET
on PR Newswire - PRF

Today's Research Reports on Trending Tickers: CVS Health and Centene

Apr. 17, 2018 at 8:36 a.m. ET
on ACCESSWIRE

CVS Health Appoints Kevin Hourican as President of CVS Pharmacy

Apr. 16, 2018 at 2:30 p.m. ET
on PR Newswire - PRF

CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in West Virginia to Help Combat Opioid Abuse

Apr. 16, 2018 at 9:15 a.m. ET
on PR Newswire - PRF

Thinking about buying stock in Alkermes, Bank of America, CVS Health Corp, The Goldman Sachs Group and Tesla Motors

Apr. 16, 2018 at 9:00 a.m. ET
on PR Newswire - PRF

CVS Health Teams Up with Job Corps to Enhance Workforce Development Opportunities for Aspiring Pharmacy Technicians

Apr. 16, 2018 at 8:00 a.m. ET
on PR Newswire - PRF

CVS Health Names Marc-David Munk, MD, MPH, MHCM, as Chief Medical Officer of MinuteClinic and Associate Chief Medical Officer of CVS Health

Apr. 13, 2018 at 10:30 a.m. ET
on PR Newswire - PRF

CVS Health Fights Back on High Cost Drugs by Launching the Industry's Most Comprehensive Approach to Saving Patients Money

Apr. 11, 2018 at 7:00 a.m. ET
on PR Newswire - PRF

CVS Health Fights Back on High Cost Drugs by Launching Industry's Most Comprehensive Approach to Saving Patients Money

Apr. 11, 2018 at 7:00 a.m. ET
on PR Newswire - PRF

Medicare Stand-Alone PDP Membership Up 1.6% According to Mark Farrah Associates

Apr. 9, 2018 at 10:11 a.m. ET
on BusinessWire - BZX

CVS Health Kept Drug Price Growth Nearly Flat and Improved Medication Adherence for PBM Clients in 2017

Apr. 5, 2018 at 12:00 p.m. ET
on PR Newswire - PRF

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI. (See Full Profile)

Sell
Under
Hold
Over
Buy

Number of Ratings 25 Full Ratings

Walmart's Reported Talks With Humana 'Fairly Unsurprising,' Says BMO

Apr. 2, 2018 at 3:39 p.m. ET
on Benzinga.com

'It Could Be In Walmart's Best Interest To Act': Morgan Stanley Breaks Down Pros, Cons Of A Humana Deal

Apr. 2, 2018 at 10:47 a.m. ET
on Benzinga.com

No Recommendation Changes after Walgreens Releases 2Q18 Results

Mar. 29, 2018 at 10:02 a.m. ET
on MarketRealist.com

Name	Chg %	Market Cap
PetMed Express Inc.	0.47%	$706.61M
BioScrip Inc.	-0.74%	$343.5M
Rite Aid Corp.	0.61%	$1.75B
Walgreens Boots Alliance Inc.	-2.61%	$64.87B

Competitor Data Provided By

Dow	24,053.17	-45.88	-0.19%
S&P 500	2,648.29	-6.51	-0.25%
Nasdaq	7,129.59	-1.11	-0.02%
GlobalDow	3,041.03	-9.00	-0.30%
Gold	1,306.00	-0.80	-0.06%
Oil	67.44	0.19	0.28%

CVS Health Corp.

$ 65.70

Customize MarketWatch

No Items in Watchlist

No Saved Watchlists

Uh oh

No Recent Tickers

CVS Health shares down 3.6% in Wednesday trading

CVS Health upgraded to buy from hold at CFRA, maintains $79 price target

CVS's stock surges 1.5% premarket after Q1 results

CVS Q1 pharmacy same-store sales up 7.3%; FactSet consensus up 5.2%

CVS Q1 same-store sales rose 4.8%; FactSet consensus 4.6%

CVS sees Aetna deal closing in the 2nd-half of the year

CVS Q1 revenue $45.69 bln vs. $44.51 bln; FactSet consensus $45.77 bln

CVS Q1 adj. EPS $1.48; FactSet consensus $1.41

CVS Q1 EPS 98 cents vs. 92 cents a year ago

Stocks

Columns

Authors

Topics

^$ 65.70